Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Chapel Hill, North Carolina
- Most recent report
- 8-K, filed Aug 10, 2026
- Incorporated
- Delaware
- Filings on record
- 974 filings
- On EDGAR
- CIK 34956
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 116
News 8 of 215
Prospectuses and Registrations 8 of 137
- S-8 Registration statement for an employee plan May 12, 2026
- S-3 Shelf registration statement Mar 24, 2026
- 424B3 Prospectus supplement for an offering Apr 23, 2025
- S-3 Shelf registration statement Apr 15, 2025
- S-8 Registration statement for an employee plan Nov 26, 2024
- 424B3 Prospectus supplement for an offering Sep 12, 2024
- S-8 Registration statement for an employee plan Aug 30, 2024
- S-3 Shelf registration statement Aug 30, 2024
Proxies 8 of 42
- DEFA14A Extra proxy material Apr 22, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 22, 2026
- DEFA14A Extra proxy material Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- PRE 14A Preliminary proxy statement Apr 9, 2025
- DEF 14A Proxy statement for a shareholder vote Sep 27, 2024
- DEFA14A Extra proxy material May 24, 2024
- DEFA14A Extra proxy material Apr 26, 2024
Ownership 8 of 326
- SCHEDULE 13G Large holder reported a passive stake Aug 18, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 12, 2026
Other 8 of 138
- ARS Annual report sent to shareholders Apr 22, 2026
- EFFECT Notice that a registration became effective Apr 1, 2026
- CORRESP Reply to SEC staff Mar 31, 2026
- UPLOAD Comment letter from SEC staff Mar 27, 2026
- ARS Annual report sent to shareholders Apr 25, 2025
- EFFECT Notice that a registration became effective Apr 23, 2025
- CORRESP Reply to SEC staff Apr 21, 2025
- UPLOAD Comment letter from SEC staff Apr 18, 2025
Everything here comes from Tenax Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.